Trial · NCT03720288
Registered outcomes22
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 22
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | diuresis and negative water balance | 72 hours | The comparison between groups for diuresis and negative water balance |
| Secondary | Number of cases with worsening of renal function | 72 hours | worsening of renal function (increase of 0.5 mg / dl or 25% increase in relation to admission creatinine) |
| Secondary | Number of cases with lowering of consciousness level | 72 hours | lowering of consciousness level |
| Secondary | Number of cases with circulatory assistance | 72 hours | need for mechanical circulatory assistance |
| Secondary | Number of cases with vasopressor | 72 hours | need for vasopressor or inotropic association |
| Secondary | Number of cases with orotracheal intubation | 72 hours | need for orotracheal intubation |
| Secondary | Number of cases with arrhythmia | 72 hours | occurrence of sustained ventricular arrhythmia |
| Secondary | Number of cases with acetazolamide side effects | 72 hours | need for suspension of acetazolamide due to side effects |
| Secondary | Number of cases of death | 72 hours | ocurrence of death |
| Secondary | Level of Base excess | 30 days | Comparison of all hemodynamic / metabolic parameters to be evaluated (base excess) |
| Secondary | Level of bicarbonate | 30 days | Comparison of all hemodynamic / metabolic parameters to be evaluated |
| Secondary | Rate of systolic and diastolic blood pressure | 30 days | Comparison of all hemodynamic / metabolic parameters to be evaluated |
| Secondary | Level of cardiac output | 30 days | Comparison of all hemodynamic / metabolic parameters to be evaluated |
| Secondary | Level of systolic volume | 30 days | Comparison of all hemodynamic / metabolic parameters to be evaluated |
| Secondary | Level of arterial lactate | 30 days | Comparison of all hemodynamic / metabolic parameters to be evaluated |
| Secondary | Level of BNP | 30 days | Comparison of all hemodynamic / metabolic parameters to be evaluated |
| Secondary | Level of troponin | 30 days | Comparison of all hemodynamic / metabolic parameters to be evaluated |
| Secondary | heart rate | 30 days | Comparison of all hemodynamic / metabolic parameters to be evaluated |
| Secondary | Level of sodium | 30 days | Comparison of all hemodynamic / metabolic parameters to be evaluated |
| Secondary | Level of potassium | 30 days | Comparison of all hemodynamic / metabolic parameters to be evaluated |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03720288/registered